Fundz

Adagio Medical reported raising $9.5 Million in an initial SEC Form D filing, from an offering of $10 Million

PRIVATENov 08, 2022

Amount Raised

$9.5 Million

$9.5 Million sold, per SEC Form D (first sale Oct 27, 2022)

Round Type

Venture

Laguna HillsBiotechnologyHealthcareHealth CareMedicalMedical Device

Who to call at Adagio Medical, and when

A new round usually means Adagio Medical is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Adagio Medical raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Adagio Medical, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Adagio Medical

Location

26051 MERIT CIRCLE

Laguna Hills, California, United States

About

Adagio Medical Holdings, Inc. (Nasdaq: ADGM) is a medical device company focused on developing and commercializing products for the treatment of cardiac arrhythmias utilizing its novel, proprietary, catheter-based Ultra-Low Temperature Cryoablation (ULTC) technology. ULTC is designed to create large, durable lesions extending through the depth of both diseased and healthy cardiac tissue. The Company is currently focused on the treatment of ventricular tachycardia (VT) with its purpose-built vCLASTM Cryoablation System which is CE Marked and is currently under evaluation in the Company’s FULCRUM-VT U.S. IDE Pivotal Study.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Adagio Medical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts12 people are listed at Adagio Medical. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Adagio Medical's next move

See what Strategic adds

Adagio Medical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.